Table 1 Baseline patient characteristics according to hematologic response status at the time of kidney transplantation.

From: Outcomes of renal transplantation in patients with AL amyloidosis: an international collaboration through The International Kidney and Monoclonal Gammopathy Research Group

Characteristic

Overall (N = 237)

TN (N = 17)

CR (N = 145)

VGPR (N = 40)

PR (N = 24)

NR (N = 11)

Age at diagnosis (years; median)

55 (26–74;)

60 (34–74;)

54 (27–70)

54 (30–74)

53 (37–70)

55 (41–64)

Male

156 (65.8%)

12 (70.6%)

91 (62.8%)

27 (67.5%)

19 (79.2%)

7 (63.6%)

Race: white

228 (96%)

17 (100%)

140 (96%)

38 (95%)

23 (95%)

10 (100%)

FLC type

 Kappa

80 (34%)

6 (35%)

50 (35%)

10 (25%)

10 (42%)

4 (36%)

 Lambda

157 (66%)

11 (65%)

95 (65%)

30 (75%)

14 (59%)

7 (64%)

Creatinine at diagnosis (µmol/L)

176 (35–1414)

190 (62–539)

197 (35–1414)

108 (35–1061)

135 (62–875)

163 (53–371)

eGFR MDRD at diagnosis

35.5 (2–139)

27 (9–97)

30 (2–139)

59 (4–135)

61.5 (6–127)

42 (16–124)

Proteinuria (grams/24 hr)

7 (0–41.8)

3.7 (0.2–26)

7.235 (0–41.8)

5.6 (0–17.6)

7.99 (0–23.2)

7.4 (0–15.3)

Co-morbidities

 DM

9 (3.8%)

0 (0.0%)

7 (4.9%)

1 (2.6%)

1 (4.2%)

0 (0.0%)

 Hypertension

76 (32.3%)

8 (47.1%)

41 (28.5%)

16 (41%)

10 (41.7%)

1 (9.1%)

 Vascular disease (CAD, MI, PAD)

21 (8.9%)

2 (11.8%)

14 (9.7%)

4 (10.3%)

0 (0.0%)

1 (9.1%)

Organ involvement

 Cardiac

96 (40.5%)

5 (29.4%)

57 (39.3%)

21 (52.5%)

8 (33.3%)

5 (45.5%)

 Renal

226 (95.4%)

17 (100%)

136 (93.8%)

38 (95%)

24 (100%)

11 (100%)

 Hepatic

55 (23.2%)

4 (23.5%)

34 (23.4%)

8 (20%)

9 (37.5%)

0 (0.0%)

 GI

38 (16%)

3 (17.6%)

20 (13.8%)

8 (20%)

5 (20.8%)

2 (18.2%)

 AN

27 (11.4%)

3 (17.6%)

11 (7.6%)

6 (15%)

5 (20.8%)

2 (18.2%)

 PN

36 (15.2%)

4 (23.5%)

17 (11.7%)

7 (17.5%)

6 (25%)

2 (18.2%)

 Pulmonary

2 (0.8%)

0 (0.0%)

1 (0.7%)

1 (2.5%)

0 (0.0%)

0 (0.0%)

 Multi organ involvement

162 (68.4%)

9 (52.9%)

95 (65.5%)

31 (77.5%)

18 (75%)

9 (81.8%)

Type of renal transplantation

 Living

131 (54%)

14 (87.5%)

82 (57.7%)

23 (60.5%)

8 (36.4%)

4 (36.4%)

 Cadaveric

106 (46%)

3 (18%)

63 (43%)

17 (42%)

16 (66%)

7 (63.6%)

  1. CR complete response, VGPR very good partial response, PR partial response, NR no response, TN treatment naive.